CompletedNot Applicable

An Innovative Silicone Wound Dressing for the Management of Atrophic Vaginitis

United States10 participantsStarted 2022-04-01

Plain-language summary

The objective of the study is to determine the efficacy of 7-0940 in the management of atrophic vaginitis in female patients

Who can participate

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Able to provide informed consent * Diagnosed acute or chronic Atrophic Vaginitis * Controlled disease, or uncontrolled disease that did not respond to standard therapy with HRT Exclusion Criteria: * Unable to provide informed consent * Patient unable to apply topical device * Allergy or intolerance to ingredients or excipients of the formulation of studied products * Currently on HRT (orally or topically) * Currently on corticosteroid treatment

What they're measuring

Patient-reported Vulvar Quality of Life

Timeframe: 3 months

Trial details

NCT IDNCT05432154

SponsorStratpharma AG

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2022-07-31

View on ClinicalTrials.gov More Atrophic Vaginitis trials